Posted in | News | Gold

Castle Peak Mining Releases Final Drilling Results from Apankrah Target

Castle Peak Mining has announced the final drilling results from the 2011 Phase I drilling evaluation conducted at Apankrah target on December 20, 2011.

The company encountered 3.3 g/t gold over 16 m in the final drill hole of the phase I program from the Nkwanta concession’s Apankrah target. It intersected 0.5 g/t gold over 14 m in the hole POWDDH005, 0.3 g/t gold over 17.8 m POWDDH006 and 1.8 g/t gold over 1.5 m in the hole POWDDH007 from the seven hole Dansuom target.

The company drilled the final hole, NKDDH016, at the Apankrah structure and encountered 12.5 g/t gold over 4 m and 3.3 g/t gold over 16 m. These drill results have validated the occurrence of high-grade shoots on the ENE trending shear structures in the metavolcanic rock package. Further drilling has been planned to commence the delineation of a high-grade resource potential. The company identified sulphide haloes towards the high-grade zones. These haloes will be explored through geophysical surveys, in order to prioritize targets on prominent analogous structures and to help in the discovery of further target structure.

Drilling completion at the Dansuom target further adds to the former intercepts of 2.9 g/t gold over 11 m, 1.0 g/t gold over 7 m and 0.5 g/t gold over 14 m from the hole POWDDH005, and 1.8 g/t gold over 1.8 m and 0.6 g/t gold over 5.3 m from the hole POWDDH007. The mineralized zone has been expanded through this drill program for a depth of 100 m and a strike of 500 m and stays exposed in every direction. A vein structure that is trending towards northeast and crossing the key Dansuom target were assessed by the hole POWDDH007, which yielded 0.6 g/t gold over 4 m. A shear zone, upon which chip sampling was conducted, encountered 0.6 g/t gold over 1 m and 0.2 g/t gold over 6 m. Further ground follow-up work will be conducted on this structure during the target generation campaign in 2012.

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 18). Castle Peak Mining Releases Final Drilling Results from Apankrah Target. AZoMining. Retrieved on November 24, 2024 from https://www.azomining.com/News.aspx?newsID=5693.

  • MLA

    Scanlon, Joel. "Castle Peak Mining Releases Final Drilling Results from Apankrah Target". AZoMining. 24 November 2024. <https://www.azomining.com/News.aspx?newsID=5693>.

  • Chicago

    Scanlon, Joel. "Castle Peak Mining Releases Final Drilling Results from Apankrah Target". AZoMining. https://www.azomining.com/News.aspx?newsID=5693. (accessed November 24, 2024).

  • Harvard

    Scanlon, Joel. 2019. Castle Peak Mining Releases Final Drilling Results from Apankrah Target. AZoMining, viewed 24 November 2024, https://www.azomining.com/News.aspx?newsID=5693.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.